|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:43AM
|
|
Re: #Covid19 Interview of Nevan Krogan, PDF of article
|
6
|
Resverlogix Corp.
|
Mar 27, 2020 10:37AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 07:03PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 06:41PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 03:39PM
|
|
Re: H1 2020 Potential Events
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 09:42PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 24, 2020 05:56PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 24, 2020 02:53PM
|
|
Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 12:59PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 24, 2020 12:56PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 24, 2020 12:51PM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
4
|
Zenith Epigenetics
|
Mar 24, 2020 12:31PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
9
|
Resverlogix Corp.
|
Mar 23, 2020 08:47PM
|
|
Re: What the media is saying now...
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 03:35PM
|
|
Re: Epigenetics and Coronavirus
|
4
|
Resverlogix Corp.
|
Mar 23, 2020 03:25PM
|
|
Re: H1 2020 Potential Events
|
7
|
Resverlogix Corp.
|
Mar 23, 2020 03:20PM
|
|
Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 08:18AM
|
|
Re: Late Breaker program?
|
4
|
Resverlogix Corp.
|
Mar 23, 2020 12:04AM
|
|
Re: BD2 specific inhibitors mentioned in Science
|
5
|
Resverlogix Corp.
|
Mar 22, 2020 02:50PM
|
|
Re: Can the Experts on this Forum tell us if this is credible?
|
3
|
Resverlogix Corp.
|
Mar 21, 2020 11:30PM
|
